Isoppads

Isoppads

SCHEMBL29494952

Cc1nc(/N=N/c2cc(S(=O)(=O)O)ccc2S(=O)(=O)O)c(COP(=O)(O)O)c(C=O)c1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 5/20 1.00
▸ TDP1 Q9NUW8 5/20 1.00
▸ P2RX3 P56373 3/20 1.00
▸ KDM4E B2RXH2 3/20 1.00
▸ P2RX2 Q9UBL9 3/20 1.00
▸ MEN1 O00255 3/20 1.00
▸ KMT2A Q03164 3/20 1.00
▸ HPGD P15428 2/20 1.00
▸ HSD17B10 Q99714 2/20 1.00
▸ P2RY1 P47900 4/20 0.86
▸ P2RX7 Q99572 3/20 0.86
▸ ALDH1A1 P00352 2/20 0.86
▸ P2RX5 Q93086 2/20 0.86
▸ P2RX4 Q99571 2/20 0.86
▸ CASP1 P29466 1/20 0.86
▸ CYP2C19 P33261 1/20 0.86
▸ RAB9A P51151 1/20 0.86
▸ CASP7 P55210 1/20 0.86
▸ ENPP1 P22413 1/20 0.74
▸ THRB P10828 2/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Isoppads SCHEMBL14702227 1.00 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL7196930 0.93 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL13624677 0.93 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL5287746 0.93 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL29357199 0.93 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL7196945 0.93 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL31236767 0.93 MAPT (1.00) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL29374112 0.88 MAPT (0.78) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL16450980 0.87 MAPT (0.79) MAPTTDP1P2RX3KDM4EP2RX2
SCHEMBL14506104 0.86 MAPT (0.75) MAPTTDP1P2RX3KDM4EP2RX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662319-A2 PERSONALIZED CRISPR PROFILING FOR CANCER Integrate Bioscience LLC (US) 2025-12-17 — — EP disclosed
WO-2024168301-A2 PERSONALIZED CRISPR PROFILING FOR CANCER FUNCTION ONCOLOGY, INC. (US) 2024-08-15 — — WO disclosed
US-11376269-B2 Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (AML) INSERM (FR) 2022-07-05 — — US disclosed
EP-3744348-B1 PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CHEMORESISTANT ACUTE MYELOID LEUKEMIA (AML) INST NAT SANTE RECH MED (FR) 2022-03-23 — — EP disclosed
Send feedback